The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look ...

Boris Becker's ex-wife Lilly looked on cloud nine as she touched down at Frankfurt Airport on Wednesday after winning the ...

Sarah O’Keeffe recounts her fulfilling career path with Eli Lilly from employee to Senior Vice President, Product Research ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

AstraZeneca’s share price has dropped recently on concerns relating to its Chinese operation, but this may have left the ...